In combination with silencing GLUT-1 to achieve ATP depletion (Fig. 1d), we synergistically downregulated the DNA homologous recombination repair capacity within gastric cancer cells, thereby enhancing ROS-mediated DNA damage therapy. The gene discussed is SLC2A1; the disease is gastric cancer.